Developing a Chatbot to Promote HIV Testing
Developing an Artificial Intelligence Chatbot to Promote HIV Testing
2 other identifiers
interventional
80
1 country
1
Brief Summary
In this study, the feasibility of a Chatbot in promoting HIV testing in a pilot RCT with 80 men who have sex with men in Kuala Lumpur, Malaysia will be studied. Participants will be randomized to Chatbot or treatment as usual (TAU) groups. Participants in the intervention group will receive automated personalized messages containing HIV testing-related information, motivation and skills.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv-infections
Started Jul 2026
Shorter than P25 for not_applicable hiv-infections
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2021
CompletedFirst Posted
Study publicly available on registry
June 2, 2021
CompletedStudy Start
First participant enrolled
July 20, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2027
Study Completion
Last participant's last visit for all outcomes
July 31, 2027
January 29, 2026
January 1, 2026
1 year
May 27, 2021
January 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in HIV testing
The efficacy of the Chatbot versus TAU with HIV testing as the primary outcome will be measured. The primacy efficacy outcome is the proportion of MSM who get tested within 180 days. This will be measured every 30 days by asking if MSM tested for HIV in the past 30 days.
30 days, 60 days, 90 days, 120 days, 150 days, and 180 days
Secondary Outcomes (4)
Recruitment rate
180 days
Completion rate
180 days
Interaction time
180 days
Interaction frequency
180 days
Study Arms (2)
Chatbot group
EXPERIMENTALTAU group
PLACEBO COMPARATORInterventions
Automated personalized messages containing HIV testing-related information, motivation and skills
Attention-matched educational materials manually sent by our research assistant. These educational materials will be retrieved from CDC and WHO websites and curated into short articles (\<200 words) and pictures. All educational materials will be screened by HIV experts from University of Malaya to ensure accuracy before being sent to participants.
Eligibility Criteria
You may qualify if:
- cis-gender male
- + years;
- had condomless sex with men in the past 6 months
- has a smartphone
- speaks Bahasa Malay or English.
You may not qualify if:
- Not able to read Malay or English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Malayacollaborator
- Yale Universitylead
- National Institute of Allergy and Infectious Diseases (NIAID)collaborator
Study Sites (1)
University of Malaya
Kuala Lumpur, Jalan Pantai Baharu, 59990, Malaysia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey A. Wickersham, PhD
Yale University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 27, 2021
First Posted
June 2, 2021
Study Start (Estimated)
July 20, 2026
Primary Completion (Estimated)
July 31, 2027
Study Completion (Estimated)
July 31, 2027
Last Updated
January 29, 2026
Record last verified: 2026-01